These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17576788)

  • 21. [Intravenous pulsed therapy with prednisolone hemisuccinate in severe forms of systemic lupus erythematosus].
    Solakov P; Atanasov K
    Vutr Boles; 1988; 27(5):72-3. PubMed ID: 3213042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
    Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
    Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review.
    Meridor K; Shoenfeld Y; Tayer-Shifman O; Levy Y
    Medicine (Baltimore); 2021 May; 100(18):e25591. PubMed ID: 33950936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocarditis as an initial manifestation of systemic lupus erythematosus.
    Routray SN; Mishra TK; Patnaik UK; Behera M
    J Assoc Physicians India; 2004 Aug; 52():673-4. PubMed ID: 15847368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.
    Zandman-Goddard G; Blank M; Shoenfeld Y
    Lupus; 2009 Sep; 18(10):884-8. PubMed ID: 19671787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spectrum of reactive hemophagocytic syndrome in systemic lupus erythematosus.
    Papo T; Andre MH; Amoura Z; Lortholary O; Tribout B; Guillevin L; Piette JC
    J Rheumatol; 1999 Apr; 26(4):927-30. PubMed ID: 10229419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endomyocardial biopsy in patients with systemic lupus erythematosus.
    Fairfax MJ; Osborn TG; Williams GA; Tsai CC; Moore TL
    J Rheumatol; 1988 Apr; 15(4):593-6. PubMed ID: 3397968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
    Toubi E; Kessel A; Shoenfeld Y
    Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study.
    Schroeder JO; Zeuner RA; Euler HH; Löffler H
    J Rheumatol; 1996 Jan; 23(1):71-5. PubMed ID: 8838511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin.
    Takizawa Y; Maruyama J; Setoguchi K
    Scand J Rheumatol; 2009; 38(6):492-4. PubMed ID: 19922027
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.
    Garcia-Carrasco M; Mendoza-Pinto C; Sandoval-Cruz M; Soto-Vega E; Beltran-Castillo A; Jimenez-Hernandez M; Graillet D; Gonzalez L; Rojas-Rodriguez J; Pineda-Almazana A; Zamudio-Huerta L; Lopez-Colombo A
    Lupus; 2010 Feb; 19(2):213-9. PubMed ID: 19965944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
    Francioni C; Fioravanti A; Gelli R; Megale F; Marcolongo R
    Recenti Prog Med; 1993 Oct; 84(10):679-86. PubMed ID: 8235034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus.
    Neuwelt CM; Lacks S; Kaye BR; Ellman JB; Borenstein DG
    Am J Med; 1995 Jan; 98(1):32-41. PubMed ID: 7825616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Indications--intravenous immunoglobulins--IVIG].
    Etzioni A; Sherer Y; Carp H; Mimouni D; Achiron A; Goddard G; Catz U; Shoenfeld Y
    Harefuah; 2005 Nov; 144(11):799-804. PubMed ID: 16358657
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe cutaneous adverse drug reaction to leflunomide: a report of two cases.
    Jian X; Guo G; Ruan Y; Lin D; Li X
    Cutan Ocul Toxicol; 2008; 27(1):5-9. PubMed ID: 18330828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis.
    Levine DS; Fischer SH; Christie DL; Haggitt RC; Ochs HD
    Am J Gastroenterol; 1992 Jan; 87(1):91-100. PubMed ID: 1728132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE).
    Goodfield M; Davison K; Bowden K
    J Dermatolog Treat; 2004 Jan; 15(1):46-50. PubMed ID: 14754650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents.
    Dooley MA; Ginzler EM
    Rheum Dis Clin North Am; 2006 Feb; 32(1):91-102, ix. PubMed ID: 16504823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiphlogistic therapy of carditis in disseminated lupus erythematosus].
    Novak V
    Reumatizam; 1974; 21(2):48-56. PubMed ID: 4825531
    [No Abstract]   [Full Text] [Related]  

  • 40. [Myocarditis in the course of disseminated lupus erythematosus].
    Checińska Z; Michowicz J; Galazka A; Doktorczyk H
    Kardiol Pol; 1969; 12(4):307-12. PubMed ID: 5363722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.